Free Virtual Education
Committed to Free Virtual Education
HERmedicine hosts free virtual education every Monday and Wednesday night from 8:00–9:00 PM ET, together with OncoMenopause™ and the OncoMenopause Consortium®. Mondays are the Monday Night Discussion Group (MNDG) for clinicians. Wednesdays are the Wednesday Night Discussion Group (WNDG), also for clinicians, with monthly survivHERS Talks and monthly HERtalks rotating into the same Wednesday slot and open to everyone. No membership required — check the schedule for what's on this week.
How to Read This Schedule
This calendar brings together all of our live programming in one place — HERtalks, MNDG, WNDG, and SurvivHERS Talks — so you can find and register for sessions by series, audience, or topic.
MNDG
Weekly women’s health clinician education.
Women's health education for women and clinicians.
WNDG
Multi-disciplinary clinician education spanning oncology, menopause and women’s health.
Education for cancer survivHERS and clinicians.
The Trust Prescription: Why Relationship Matters More Than Technology - Tara Sanft, MD
Dr. Tara Sanft, Director of the Cancer Survivorship Program at Yale Cancer Center and chair of the NCCN Survivorship Guidelines, reviews the research on patient-provider trust: why it matters, what it changes about clinical outcomes, and what the evidence says good providers actually do to earn it. Drawing on her work as Chief Patient Experience Officer at Smilow Cancer Hospital and her role directing Yale's Communication Skills Curriculum, she offers clinicians practical, evidence-based tools for building trust in the exam room — not just theory.
Update on WISDOM - Allison Stover Fiscalini, MPH
Allison Stover Fiscalini, MPH, presents the latest WISDOM study findings — comparing personalized, risk-based breast cancer screening to annual mammography — and what the Phase 1 data means for clinical screening guidelines and shared decision-making. Free live MNDG, Sept 21 at 8 PM ET.
Sleep at Midlife - Shelby Harris, PsyD, DBSM
Midlife sleep complaints rarely present cleanly. Vasomotor symptoms, mood changes, alcohol, and years of accumulated sleep effort stack on one another, and the patient usually arrives asking for a prescription. Shelby Harris, PsyD, DBSM — Clinical Associate Professor in Neurology and Psychiatry at Albert Einstein College of Medicine and former director of Montefiore's Behavioral Sleep Medicine Program — joins WNDG to work through what's actually treatable, where CBT-I fits as first-line care, and how to sort hormonal disruption from primary insomnia. Bring your cases. Wednesday, September 23, 8:00–9:00 PM ET.
Adolescent Gynecology - Leslie Appiah, MD
Leslie Appiah, MD, a nationally recognized leader in reproductive health equity, delivers a focused, practical session on adolescent gynecology for non-specialist providers — covering common presentations, referral criteria, and affirming, equity-centered approaches to care. Free live MNDG, Sept 28 at 8 PM ET.
OMC Monthly Case Rounds - Milana V. Dolezal, MD, MSci
OMC Monthly Case Rounds launches September 30 with Milana V. Dolezal, MD, MSci. This live, clinician-only session works through real, de-identified cases in oncology and menopause care — held monthly through OncoMenopause and the OncoMenopause Consortium®.
Migraine During Perimenopause - Katherine T. Hamilton, MD
Katherine Hamilton, MD, headache specialist at MedStar Georgetown's Headache Center, delivers a clinical framework for migraine during perimenopause — covering acute and preventive treatment evidence and practical considerations around hormone therapy in this population. Free live MNDG, Oct 5 at 8 PM ET.
Obesity Medicine - What’s New - Tracy Norfleet MD, MBA, DABOM, DipABLM, FACP
Obesity medicine has shifted fast, and the headlines don't always match the clinical picture. Dr. Tracy Norfleet — a triple board-certified physician in internal medicine, obesity medicine, and lifestyle medicine — breaks down the newest medication options, what's changed in medical guidance, and how to separate genuine progress from hype. Join this free HERtalks session on October 7 at 8 PM ET for a clearer, shame-free look at where obesity care stands today.
Complex Menopause Cases - Risa Kagan, MD, FACOG, CCD, MSCP
Risa Kagan, MD, FACOG, CCD, MSCP — one of the country's leading menopause specialists — uses a case-based format to work through complex clinical scenarios that go beyond standard guidelines, sharpening decision-making for patients who don't fit the algorithm. Free live MNDG, Oct 12 at 8 PM ET.
What Clinicians Need to Know When Caring for Survivors of Childhood Cancers - Rebecca L. Eary, DO, MPH & Melissa Erickson, MD
Adult survivors of childhood cancer represent a growing and clinically complex population — one that women's health and oncomenopause providers are increasingly likely to encounter and often feel underprepared to serve. Drs. Eary and Erickson, whose careers are built around bridging the gap between oncology and survivorship primary care, deliver a practical, evidence-informed session on what clinicians need to know when these patients walk through their door.
The Menopause Society’s 2026 Annual Meeting Bridging the Gap Between Research and Practice
Registration opened today for The Menopause Society's 2026 Annual Meeting in San Diego — and the 2025 Exhibit Hall sold out. Is this the year you finally make it?
Orgasm - Lauren Streicher, MD, FACOG, MSCP
Lauren Streicher, MD, FACOG, MSCP, founder of Northwestern's Center for Menopause and Sexual Health, reviews orgasmic dysfunction across the menopausal transition — mechanisms, hormonal contributors, and both pharmacologic and non-pharmacologic treatment options. Free live MNDG, Oct 26 at 8 PM ET.
HSDD and Sexual Health in Cancer Survivors - Heather Quaile, DNP
Dr. Heather Quaile addresses HSDD, one of the most underdiagnosed conditions affecting women after cancer — what it is, how treatment contributes to it, and the evidence-based options available to help.
Precision Breast Health - Radiomics and AI in Breast Imaging - Connie Lehman, MD, PhD
Connie Lehman, MD, PhD, brings the science of AI and radiomics in breast imaging to MNDG — exploring how these tools are reshaping risk stratification, screening precision, and clinical decision-making in breast health. Free live MNDG, Nov 2 at 8 PM ET.
Beyond Hormones - Options for Menopause Besides MHT - Laurie S. Jeffers, DNP, FNP-BC, MSCP
Non-hormonal menopause treatment has moved fast in recent years, and it can be hard to know what's actually available versus what's just headlines. Laurie Jeffers, DNP, FNP-BC, MSCP — cofounder of the Center for Midlife Health and Menopause at NYU Langone and a longtime Menopause Society leader — walks through the newer medication options and nonpharmacologic approaches shaping menopause care today. Join this free HERtalks session on November 4 at 8 PM ET for a clearer picture of what's worth asking your own doctor about.
Endometriosis - Hugh Taylor, MD
Women still wait roughly a decade for an endometriosis diagnosis, and much of that delay happens in primary care and general gynecology, where cyclic pain gets normalized visit after visit. Hugh Taylor, MD — Anita O'Keeffe Young Professor and Chair of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, Chief of Ob/Gyn at Yale New Haven Hospital, and a member of the National Academy of Medicine — joins MNDG to talk through what should raise suspicion earlier, how medical management has changed, where surgery still belongs, and what the work on non-invasive diagnostics and precision treatment is likely to change. Monday, November 9, 8:00–9:00 PM ET.
Menopause Management in Gynecologic Cancer Survivors - Rachel Frankenthal, PA-C
An evidence-based review of menopause management strategies for gynecologic cancer survivors, with practical guidance for individualized, survivorship-centered care.
Breast Health and MHT: How to Counsel Women at Elevated Risk - Sabrina Sahni, MD, MSCP
Sabrina Sahni, MD, MSCP, with dual expertise in specialized women's health and medical breast medicine, delivers a structured framework for MHT counseling spanning benign breast disease, dense breasts, BRCA carriers, and cancer survivors. Free live MNDG, Nov 16 at 8 PM ET.
The Midlife Women’s Health Update - Evidence Based Menopause Care in the Era of Longevity Medicine
The 2026 Midlife Women's Health Summit is a three-day menopause CME co-chaired by Larkin, Gunter, and Streicher — covering menopause management, hormonal health, sexual medicine, and longevity medicine through case-based sessions. 18 AMA PRA Category 1 Credit(s)™. Nov 20–22, The Ritz-Carlton, Pentagon City, VA.
Your Body, Your Plate: Nutrition Through Cancer-Related Menopause - Erin Pellegrin, RD, LDN
Cancer-related menopause differs from natural menopause in onset and physiology, and the nutritional needs that follow differ too. Erin Pellegrin, RD, LDN, Senior Director of Culinary Nutrition and Education at Unite for HER, joins MNDG to present the culinary nutrition framework her team uses to counsel breast and ovarian cancer patients through treatment and survivorship — food-based approaches to common side effects, risk-reduction and cardiometabolic considerations, and where nutrition counseling fits into the broader care plan. She'll close with practical talking points clinicians can use when patients raise diet and weight change during survivorship visits.
The Rationale For Checking Estradiol Levels - James A. Simon, MD, CCD, MSCP, IF, FACOG & Sarah Glynne, MBBS, MSc, MRCP, MRCGP
James Simon, MD, MSCP, IF and Sarah Glynne, MBBS, MSc, MRCP, MRCGP, bring complementary US and UK clinical perspectives to estradiol monitoring in MHT — presenting a structured case for monitoring as a tool to optimize dosing, address persistent symptoms, and manage safety in complex patients. Free live MNDG, Nov 30 at 8 PM ET.
Your Hormones Are Not Failing You: The Truth About Midlife Metabolism and Your Changing Body - Kimberley Sampson-Paine, MD, MSc
Midlife metabolic changes aren't a personal failure, and the old advice to eat less and move more rarely tells the full story. Dr. Kimberley Sampson-Paine — a triple board-certified OB/GYN, obesity medicine specialist, and lifestyle medicine physician at Southwestern Vermont Medical Center — explains what's actually happening with hormones, weight, and insulin sensitivity at midlife, and what a more effective approach looks like. Join this free HERtalks session on December 2 at 8 PM ET for a clearer, more compassionate understanding of your changing body.
Nutrition Guidelines and Fitness for Health: What you Should Know in The Era of Social Media and the New Guidelines - Karl Nadolsky, DO, FACE, DABOM & Spencer Nadolsky, DO, DABOM
Karl and Spencer Nadolsky, DO — endocrinologists with combined expertise in obesity medicine and evidence-based health communication — review the new nutrition and physical activity guidelines and how to counsel patients who walk in with strong, algorithm-driven opinions. Free live MNDG, Dec 7 at 8 PM ET.
PMOS - Basma Faris, MD, MS, FACOG, CCMS
PCOS became PMOS this year, and the name change was never really about nomenclature. It was an acknowledgment that a condition affecting roughly one in ten reproductive-age patients is a lifelong cardiometabolic diagnosis, not a fertility problem with a cosmetic side. Basma Faris, MD, MS, FACOG, CCMS — Assistant Professor of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, who came to medicine from clinical nutrition — joins WNDG to talk about what comprehensive PMOS care actually requires: metabolic screening, nutrition counseling that survives contact with a real patient's life, and long-term management in a system built around episodic visits. Wednesday, December 9, 8:00–9:00 PM ET.
Hereditary Cancer Risk Management - Michelle Jacobson, MD, FRCSC
Michelle Jacobson, MD, FRCSC, a lead author of national hereditary cancer and menopause management guidelines, delivers a focused clinical review of BRCA counseling, risk-reducing surgery, surveillance protocols, and menopause care for high-risk patients. Free live MNDG, Dec 14 at 8 PM ET.
Beyond the Bell: Survivorship Challenges After Gynecologic Cancer. - Mercedes Castiel, MD, FRCSC, FACOG, MSCP
Dr. Mercedes Castiel walks through practical, take-home guidance for life after cancer: communicating with your care team, managing peri- and menopause symptoms, and risk-reducing strategies that fit your journey.
Thyroid Update: Post Partum Thyroditis, Hashimotos, Graves - Abid Yaqub, MD, FACP, FACE, FCPS
Abid Yaqub, MD, FACP, FACE, FCPS, thyroid specialist at the University of Cincinnati, reviews postpartum thyroiditis, Hashimoto's, and Graves' disease — overlapping presentations, diagnostic workup, and the management decisions that matter most for women's health providers. Free live MNDG, Dec 21 at 8 PM ET.
Heart Disease in Cancer Survivors - CardioOncology - Susan Dent, MD, FRCPC
An evidence-based overview of cardio-oncology, focusing on cardiovascular risk, treatment-related cardiotoxicity, and long-term heart health in cancer survivors.
Recovering Healthcare - What Addiction Can Teach Us About Fixing a Broken Healthcare System - Tony Grandelis, MD
Dr. Tony Grandelis, an OBGYN hospitalist and physician in recovery from addiction, explores how honesty, community, integrity, and whole-person care can reshape a healthcare system that too often feels fragmented and impersonal.
Alzheimer’s Genetics Reinterpreted, Alzheimer’s Disease Redefined - Alberto Espay, MD, MSc, FAAN, FANA
Alberto Espay, MD, MSc, FAAN, FANA, Professor at the University of Cincinnati, examines emerging genetic insights redefining Alzheimer's disease — including evolving risk models, diagnostic implications, and therapeutic approaches. Free live MNDG, Aug 31 at 8 PM ET.
Update on Breast Cancer for the Women's Health Clinician - Matthew Kurian, MD
Breast cancer care moves faster than most women's health clinicians can track alongside a full panel, and the questions land in your office regardless — from the patient weighing a treatment decision, the survivor asking what her surveillance should look like, and the woman with a family history who wants to know what her risk actually is. Matthew Kurian, MD — medical oncologist at St. Elizabeth Healthcare and Assistant Professor of Medicine at the University of Kentucky College of Medicine, with a clinical focus in breast and genitourinary malignancies — joins WNDG for an update built for the clinician who isn't an oncologist but is often the first call. Wednesday, August 26, 8:00–9:00 PM ET.
Type 2 Diabetes Management: Medications Other Than GLP’1s - Jyothi Joseph-Hayes, MD
Jyothi Joseph-Hayes, MD provides a practical, evidence-based review of Type 2 diabetes pharmacotherapy beyond GLP-1 receptor agonists — covering the full range of medication classes and considerations for individualized treatment decisions. Free live MNDG, Aug 24 at 8 PM ET.
Early Cancer Detection: What You Should Know About New Blood-Based Early Cancer Detection Tests - Candace Westgate, DO, MPH, FACOG, MSCP
Multi-cancer early detection tests are changing what proactive health looks like for survivors and high-risk women. Dr. Candace Westgate breaks down how these blood-based tests work, what they can and can't tell you, and who they're designed for.
Vulvar Disorders of Menopause, Carrie Sopata, MD, MPH
Vulvar disorders of menopause span a wide differential — from atrophic changes to lichen sclerosus and other dermatologic conditions — and are frequently misdiagnosed or dismissed as routine atrophy. Dr. Carrie Sopata, who directs UVA's multidisciplinary vulvar dermatology clinic, reviews the diagnostic approach to vulvar complaints in menopausal patients, including exam findings, when biopsy is indicated, and current treatment options. This MNDG session is free to attend.
Menopause Myth Busters: Rethinking Inclusive Oncomenopause Care for High-Priority Patient Populations - Dr. Janeane Anderson, Dr. Sameena Rahman & Dr. Kudzai Dombo
Advanced breast cancer outcomes, vulvovaginal disease, and menopause care all show the same disparity pattern. Anderson, Rahman, and Dombo trace where shared decision-making breaks down first for high-priority patient populations.
As the Menoverse Expands: When Does Perimenopause Begin and How Can We Help? - Marcie Richardson, MD, FACOG
Marcie Richardson, MD, FACOG, reviews the science of perimenopause onset — including the Late Reproductive Stage — and offers practical strategies for identifying and supporting women earlier in the hormonal transition. Free live MNDG, Aug 10 at 8 PM ET.
Breast Cancer Risk Assessment and Prevention - Dr. Lisa Larkin, MD, FACP, MSCP, IF
Breast cancer is the most common cancer among women — but knowledge is your most powerful tool. In this HERtalks consumer education event, Dr. Lisa Larkin walks you through breast cancer risk assessment and prevention, covering key risk factors, screening guidelines, and the prevention strategies that can make a real difference in your health.
Pain with Sex - Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR
Pain with sex affects a significant proportion of midlife women — and most providers don't have a systematic framework for addressing it. Dr. Jen Gunter, one of women's health's most recognized and evidence-driven voices, reviews the full clinical picture: how to differentiate GSM from vulvodynia from pelvic floor dysfunction, what the evidence supports for treatment, and how to have the clinical conversations that move patients toward relief.
Approach to First-Line Migraine Prevention Redefined - Qulipta - Hope O’Brien, MD, MBA, FAAN, FAHS
Migraine preventive therapy has followed a predictable order for years: oral agents first, CGRP-targeted therapies reserved for treatment failures. Dr. Hope O'Brien, founder of the Headache Center of Hope and adjunct faculty at the University of Cincinnati College of Medicine, reviews the evidence testing that hierarchy and where updated guidance is changing first-line decisions. This MNDG session is free to attend.
Update on DCIS - Laura J. Esserman, MD, MBA
Ductal carcinoma in situ is evolving rapidly — and so is the evidence guiding its management. In this CME session, Dr. Laura Esserman provides a current, evidence-based review of DCIS diagnosis, risk stratification, and treatment, including emerging data on active surveillance and the growing movement away from overtreatment.
The Great Menopause Debate - The NEW ACOG Guidelines: Evaluation of Postmenopausal Bleeding - Steven R. Goldstein, MD, CCD, MSCP, FACOG
Steven Goldstein, MD, CCD, MSCP, FACOG — developer of saline infusion sonohysterography and a leading voice in menopausal ultrasound — critically examines the new ACOG postmenopausal bleeding guidelines: what the evidence supports, and what it doesn't. Free live MNDG, July 13 at 8 PM ET.
Breast Cancer Genetics and Cancer Risk Reduction - Allison W. Kurian, MD, MSc
Allison Kurian, MD, MSc, Director of Stanford's Women's Clinical Cancer Genetics Program, reviews multigene panel testing, the evolving evidence on moderate-risk genes, and how to translate genetic results into clinical action for breast cancer risk. Free live MNDG, June 29 at 8 PM ET.
MCED Testing Beyond Galleri: Cancerguard and Shield MCD - Candace Westgate, DO, MPH, FACOG, MSCP
Candace Westgate, DO, MPH, FACOG, MSCP, Director of Personalized Medicine at Community Health Network, compares CancerGuard and Shield MCD — technologies, validation data, and counseling frameworks — for clinicians navigating MCED conversations. Free live MNDG, June 22 at 8 PM ET.
2026 Women's Health Update
The 2026 Women's Health Update is a comprehensive one-day CME covering MHT prescribing, GLP-1 therapies and cardiometabolic risk, CVD risk assessment, and breast cancer screening — with interactive cases and a networking reception. June 19, 2026 at The Summit Hotel, Cincinnati. Limited seating.
Update on Treatment of FSD - Sharon Parish, MD & Sheryl Kingsberg, PhD
Sharon Parish, MD and Sheryl Kingsberg, PhD — two nationally recognized experts in female sexual medicine — deliver a focused update on FSD at midlife, covering testosterone, hormone therapy, HSDD pharmacology, and GSM treatment. Free live MNDG, June 15 at 8 PM ET.
Update on NKT's for VMS - Jill Liss, MD, MSCP, FACOG
Jill Liss, MD, MSCP, FACOG, Associate Clinical Professor at the University of Colorado, reviews NK3 receptor antagonists for vasomotor symptoms — mechanism, fezolinetant and elinzanetant trial outcomes, and patient selection criteria. Free live MNDG, June 8 at 8 PM ET.
Metabolic Disease in Midlife - Susan Brian, MD
Susan Brian, MD, endocrinologist at the Cotton-O'Neil Clinical Research Center, reviews diabetes, insulin resistance, and cardiometabolic risk as they evolve in midlife women. The June 1 MNDG covers risk stratification and evidence-based management.
Memorial Day - No MNDG
In honor of Memorial Day, HERmedicine's Monday Night Discussion will not meet on May 26th. We'll be back the following week with more women's health education. Wishing our community a meaningful and restful holiday.
Microbiome and Menopause: What is the Evidence - Dragana Skokovic-Sunjic, RPh, BScPhm, MSCP
The gut microbiome plays a surprising and significant role in women's hormonal health — and its connection to menopause is an area of rapidly growing research. In this HERtalks event, pharmacist and microbiome specialist Dragana Skokovic-Sunjic breaks down what the current evidence tells us and what it means for women navigating the menopausal transition.
Special Topics and What’s New in Contraception - James A. Simon, MD, CCD, MSCP, IF, FACOG
The contraception landscape has more options than ever — and the evidence guiding their use continues to evolve. Dr. James Simon, reproductive endocrinologist and one of women's health's most prolific clinical researchers, brings his signature depth and clinical precision to an up-to-date review of new contraceptive methods, safety considerations, and patient selection for clinicians who counsel and prescribe across the reproductive lifespan.
Who Owns Menopause Care? Business Models, Clinical Scope, and Standard of Care - Lisa Chacko, MD, MP, MSCP
Dr. Lisa Chacko, founder of Curate Medical and architect of the "menopause-informed care" framework, examines the forces reshaping menopause care delivery — and what clinicians need to know to stay ahead of them.
Integrating Botanicals into Midlife: What is the Evidence? - Suzanne Gilberg-Lenz, MD, FACOG
Dr. Suzanne Gilberg-Lenz examines what we actually know about commonly used botanical therapies at midlife — efficacy, safety, drug-herb interactions, and how to translate evolving evidence into grounded, patient-centered care.
The Pelvic Pain Pentad: Endometriosis · MCAS · POTS · hEDS · Pelvic Venous Disease - Jennifer Lanoff, WHNP-BC, MSCP, JD
Jennifer Lanoff, WHNP-BC, MSCP, presents a clinician framework for identifying the Pelvic Pain Pentad — endometriosis, MCAS, POTS, hEDS, and pelvic venous disease — and the overlapping presentations that make this constellation so frequently missed.
Update on GLP1's- Injectable, Oral, and Pipeline - Angela Fitch, MD, FACP, FOMA
This clinician education session with Angela Fitch, MD, FACP, FOMA, provides an up-to-date review of GLP-1–based therapies, including injectable and oral options and agents in the development pipeline. The discussion covers mechanisms of action, efficacy and safety data, clinical indications, and practical considerations for prescribing and patient counseling.
Mammography for Breast Cancer Screening- Where we are in 2026 - Anjali Malik, MD
This clinician education session with Anjali Malik, MD, reviews the current state of mammography for breast cancer screening in 2026. The discussion addresses evolving screening guidelines, advances in imaging technology, breast density considerations, and ongoing areas of clinical debate to support evidence-based screening and patient counseling.
Ovarian Cancer Screening - Mitchell Clark, MD, MPH
This clinician education session with Mitchell Clark, MD, MPH, examines the current evidence surrounding ovarian cancer screening. The discussion reviews population-level data, screening limitations, risk stratification, and guideline recommendations, with a focus on applying evidence to patient counseling and shared decision-making in clinical practice.
Progestin 2.0 - Tami S. Rowen, MD, MS
Not all progestins are created equal — and the differences matter for your patients. Dr. Tami Rowen brings her expertise in sexual medicine, menopause, and complex gynecologic care to break down the evolving progestogen landscape and its implications for your prescribing practice.
Past Monday Night Discussions
Explore a selection of past speakers who have helped shape the conversations in Monday Night Discussions, bringing expertise, insight, and diverse perspectives to each session.